Aebi, S

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 28.

Jerusalem, G; Farah, S; Courtois, A; Chirgwin, J; Aebi, S; Karlsson, P; Neven, P; Hitre, E; Graas, M P; Simoncini, E; Abdi, E; Kamby, C; Thompson, A; Loibl, S; Gavilá, J; Kuroi, K; Marth, C; Müller, B; O'Reilly, S; Gombos, A; ... (2021). Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy. Annals of oncology, 32(10), pp. 1256-1266. Elsevier 10.1016/j.annonc.2021.07.017

Pagani, O; Klingbiel, D; Ruhstaller, T; Nolè, F; Eppenberger, S; Oehlschlegel, C; Bernhard, Jürg; Brauchli, P; Hess, D; Mamot, C; Munzone, E; Pestalozzi, B; Rabaglio, Manuela; Aebi, S; Ribi, K; Rochlitz, C; Rothgiesser, K; Thürlimann, B; von Moos, R; Zaman, K; ... (2017). Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99. Annals of oncology, 28(2), pp. 305-312. Oxford University Press 10.1093/annonc/mdw622

Hamzic, Seid; Kummer, Dominic; Milesi, S; Mueller, D; Joerger, M; Aebi, S; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2017). Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity. Clinical pharmacology & therapeutics, 102(5), pp. 796-804. Wiley 10.1002/cpt.641

Girardin, D; Ballabio, N; Imboden, S; Pfaltz, K; Tapia, C; Jaggi, R; Altermatt, HJ; Aebi, S; Mueller, MD; Günthert, A (2013). Diskrepanz der klinisch-pathologischen "intrinsischen" Subtypen (IHC-Klassifikation, St-Gallen Konzensus 2011) zwischen Primärtumore und Lokalrezidive verglichen mit Diskrepanz zwischen Primärtumore und asynchrone Zweittumore beim Mammakarzinom. In: Jahreskongress SGGG, Lugano 2013. Jahreskongress SGGG, Lugano 2013

Burmeister, H; Aebi, S; Studer, C; Fey, M.F.; Gautschi, O (2012). Adherence to ESMO clinial recommendations for prophylaxis of chemotherapy-induced nausea and vomiting. Supportive care in cancer, 20(1), pp. 141-7. Berlin: Springer 10.1007/s00520-010-1079-3

Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448

Aebi, S; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Lindtner, J; Snyder, R; Karlsson, P; Simoncini, E; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Annals of oncology, 22(9), pp. 1981-7. Oxford: Oxford University Press 10.1093/annonc/mdq754

Moor, A E; Guevara, C; Altermatt, H J; Warth, R; Jaggi, R; Aebi, S (2011). PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. Pathobiology, 78(3), pp. 140-8. Basel: Karger 10.1159/000323809

Aebi, S; Davidson, T; Gruber, G; Cardoso, F (2011). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 22(Suppl 6), vi12-24. Oxford University Press 10.1093/annonc/mdr371

Zbinden, S; Bühlmann, M; Aebi, S; Suter, T (2010). Kardiovaskuläre Nebenwirkungen der modernen, medikamentösen Krebstherapie. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, pp. 143-147. Basel: EMH Editores Medicorum Helveticorum

Eicher, M; Aebi, S; Biedermann, M; Günthert, A; Keller, T; Mueller, M; Zeyen, B (2010). Breast Care Nurse - Rollen, Kompetenzen und Funktionen. Newsletter der Deutschen Gesellschaft für Senologie, der Österreichischen Gesellschaft für Senologie und der Schweizerischen Gesellschaft für Senologie, p. 2. Stuttgart: Thieme

Imboden, S; Burger, H; Aebi, S; Mohr, S; Mueller, MD (2010). Der unklare Adenexbefund. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 10(42), pp. 737-738. Basel: EMH Editores Medicorum Helveticorum

Johann, S; Santi, A; Günthert, A; Lössl, K; Aebi, S; Mueller, MD (2010). Das Endometriumkarzinom: Diagnostik, Therapie und Nachsorge. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 10(7), pp. 129-33. Basel: EMH Editores Medicorum Helveticorum

Colleoni, M; Sun, Z; Martinelli, G; Basser, R L; Coates, A S; Gelber, R D; Green, M D; Peccatori, F; Cinieri, S; Aebi, S; Viale, G; Price, K N; Goldhirsch, A (2009). The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Annals of oncology, 20(8), pp. 1344-51. Oxford: Oxford University Press 10.1093/annonc/mdp024

Amstutz, U; Farese, S; Aebi, S; Largiadèr, CR (2009). Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: A haplotype assessment. Pharmacogenomics, 10(6), pp. 931-944. London: Future Medicine 10.2217/PGS.09.28

Bartholomeyczik, S; Schnell, M; Aebi, S (2008). [Effectiveness of specialized nursing for patients with breast cancer and other gynecologic cancers: a prospective, longitudinal, two-arm pilot study in Switzerland]. Pflege - die wissenschaftliche Zeitschrift für Pflegeberufe, 21(5), pp. 353-4. Bern: H. Huber 10.1024/1012-5302.21.5.353

Aebi, S; Loibl, S (2008). Breast cancer during pregnancy: medical therapy and prognosis. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 178, pp. 45-55. Berlin: Springer

Bernhard, J; Zahrieh, D; Zhang, J J; Martinelli, G; Basser, R; Hürny, C; Forbes, J F; Aebi, S; Yeo, W; Thürlimann, B; Green, M D; Colleoni, M; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Goldhirsch, A; Coates, A S (2008). Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, 98(1), pp. 25-33. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6604092

Aebi, S; Castiglione, M (2008). Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 19 Suppl 2, ii14-6. Oxford: Oxford University Press 10.1093/annonc/mdn073

Harter, P; Aebi, S; Hilpert, F; du Bois, A (2008). Primär- und Rezidivtherapie des Ovarialkarzinoms. Onkologe, 14(11), pp. 1140-1150. Heidelberg: Springer-Medizin-Verlag 10.1007/s00761-008-1473-3

Eicher, M; Aebi, S (2008). Breast Care Nurses: Erstes Deutschsprachiges Lehrbuch erschienen. Schweizer Krebsbulletin / Bulletin suisse du cancer(4), p. 297. Bellinzona: Istituto oncologico della Svizzera Italiana

Bernhard, J; Zahrieh, D; Castiglione-Gertsch, M; Hürny, C; Gelber, RD; Forbes, JF; Murray, E; Collins, J; Aebi, S; Thürlimann, B; Price, KN; Goldhirsch, A; Coates, AS; International, Breast Cancer Study Group Trial VIII (2007). Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. Journal of clinical oncology, 25(3), pp. 263-70. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.5393

Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thürlimann, B; Mendiola, C; Aebi, S; Price, K N; Pagani, O; Simoncini, E; Castiglione Gertsch, M; Gelber, R D; Coates, A S; Goldhirsch, A (2007). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of oncology, 18(4), pp. 701-8. Oxford: Oxford University Press 10.1093/annonc/mdl492

Aebi, S; Castiglione, M (2006). The enigma of young age. Annals of oncology, 17(10), pp. 1475-7. Oxford: Oxford University Press 10.1093/annonc/mdl330

Colleoni, M; Gelber, S; Goldhirsch, A; Aebi, S; Castiglione-Gertsch, M; Price, KN; Coates, AS; Gelber, RD; International, Breast Cancer Study Group (2006). Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. Journal of clinical oncology, 24(9), pp. 1332-41. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.0783

Basser, RL; O'Neill, A; Martinelli, G; Green, MD; Peccatori, F; Cinieri, S; Coates, AS; Gelber, RD; Aebi, S; Castiglione-Gertsch, M; Viale, G; Price, KN; Goldhirsch, A; International, Breast Cancer Study Group (2006). Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95. Journal of clinical oncology, 24(3), pp. 370-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.5196

Kaiser, P C; Körner, M; Kappeler, A; Aebi, S (2005). Retinoid receptors in ovarian cancer: expression and prognosis. Annals of oncology, 16(9), pp. 1477-1487. Oxford University Press 10.1093/annonc/mdi265

Hathaway, LJ; Stutzmann Meier, P; Bättig, P; Aebi, S; Mühlemann, K (2004). A homologue of aliB is found in the capsule region of nonencapsulated Streptococcus pneumoniae. Journal of bacteriology, 186(12), pp. 3721-9. Washington, D.C.: American Society for Microbiology 10.1128/JB.186.12.3721-3729.2004

This list was generated on Fri Mar 29 03:10:08 2024 CET.
Provide Feedback